No article text was recorded for this version.
tumor-specific glycoepitope targeting
Version 2 of 28 papers21 conceptsfrozen 2026-10-04
Papers in this version
- Blog: Targeting a Tumor-Specific Epitope on Podocalyxin Increases Survival in Human Tumor Preclinical Models
- Blog: Identification of a monoclonal antibody that targets PD-1 in a manner requiring PD-1 Asn58 glycosylation
- Blog: 1364 Discovery of NXA01, a novel CD24 antibody with tumor selectivity and potent anti-tumor activity
- Blog: PODO447: a novel antibody to a tumor-restricted epitope on the cancer antigen podocalyxin
- Blog: Establishment and validation of a plasma oncofetal chondroitin sulfated proteoglycan for pan-cancer detection
- Blog: Epitopes of MUC1 Tandem Repeats in Cancer as Revealed by Antibody Crystallography: Toward Glycopeptide Signature-Guided Therapy
- Blog: Prostaglandin F2 receptor negative regulator as a potential target for chimeric antigen receptor-T cell therapy for glioblastoma
- Blog: SEPPA 3.0 - enhanced spatial epitope prediction enabling glycoprotein antigens
History & citation
Current · Permanent link
Cite this direction
Latest version (a living page):
@misc{lacuna_tumor_specific_glycoepitope_targeting_99df8903,
title = {tumor-specific glycoepitope targeting},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/tumor-specific-glycoepitope-targeting/rdr_99df890376e142728341c738a1ebacd2},
note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-19},
}This exact version (version 2, frozen text):
@misc{lacuna_tumor_specific_glycoepitope_targeting_99df8903_v2,
title = {tumor-specific glycoepitope targeting},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/tumor-specific-glycoepitope-targeting/rdr_99df890376e142728341c738a1ebacd2/v/2},
note = {Version 2, frozen 2026-10-04. Accessed 2026-11-19},
}